LINDSAY GAMBLE, APRN, FNP-C
Family Nurse Practitioner · OKATIE, SC
Individual Active NPI 1740790179
Medicare payment data Part B · 2024
| Year | Beneficiaries | Services | Submitted | Allowed | Paid |
|---|---|---|---|---|---|
| 2024 | 859 | 371,167 | $35,703,985 | $10,467,604 | $8,314,455 |
| 2023 | 747 | 339,412 | $30,145,296 | $9,350,888 | $7,432,336 |
| 2022 | 553 | 238,964 | $22,312,217 | $7,306,853 | $5,811,081 |
Top procedures (2024)
| HCPCS | Description | Services | Avg allowed | Avg paid |
|---|---|---|---|---|
| J0897 | Injection, denosumab, 1 mg | 40,680 | $26 | $20 |
| J3111 | Injection, romosozumab-aqqg, 1 mg | 39,690 | $11 | $9 |
| J1306 | Injection, inclisiran, 1 mg | 36,636 | $12 | $9 |
| J3380 | Injection, vedolizumab, intravenous, 1 mg | 29,100 | $22 | $17 |
| J2182 | Injection, mepolizumab, 1 mg | 16,600 | $30 | $24 |
| J3245 | Injection, tildrakizumab, 1 mg | 10,700 | $135 | $107 |
| J2357 | Injection, omalizumab, 5 mg | 8,325 | $38 | $30 |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | 6,260 | $31 | $25 |
| J9312 | Injection, rituximab, 10 mg | 3,950 | $74 | $59 |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | 2,946 | $0 | $0 |
| J0517 | Injection, benralizumab, 1 mg | 1,530 | $165 | $131 |
| 96372 | Injection of drug or substance under skin or into muscle | 1,506 | $11 | $9 |
Taxonomy & licensure
| Specialty | Code | Primary | License | State |
|---|---|---|---|---|
| Family Nurse Practitioner | 363LF0000X | ✓ | RN22890 | SC |
Medicare eligibility
- Part B
- Yes
- DME
- Yes
- Home health
- Yes
- Power mobility
- Yes
- Hospice
- No
Other Family Nurse Practitioner providers in South Carolina
- NPI 1538834056
- NPI 1912088634
- NPI 1255146841
- NPI 1205666807
- NPI 1336954007
- NPI 1548068174
- NPI 1164257416
- NPI 1215825625
See all Family Nurse Practitioner providers in South Carolina →
Source: NPPES (public domain) and CMS Medicare Physician & Other Practitioners data. Not affiliated with CMS, NPPES, or any government agency.